|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7068 | (2006.01) |
| A61K 31/7068 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61K 47/54 | (2017.01) |
| (11) | Number of the document | 3383407 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16870114.2 |
| Date of filing the European patent application | 2016-01-25 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2016/050077 |
| Date | 2016-01-25 |
| (87) | Number | WO 2017/093993 |
| Date | 2017-06-08 |
| (30) | Number | Date | Country code |
| 201562262428 P | 2015-12-03 | US |
| (72) |
GENGRINOVITCH, Stela , IL
BEN YAKAR, Ruth , IL
|
| (73) |
BioSight Ltd. ,
3 Hayarden Street
Airport City, P.O.Box 1083, Lod 7019802,
IL
|
| (54) | CYTARABINE CONJUGATES FOR CANCER THERAPY |
| CYTARABINE CONJUGATES FOR CANCER THERAPY |